A Randomized, Double-blind Study To Assess The Efficacy And Safety Of Prophylactic Use Of Maribavir Versus Oral Ganciclovir For The Prevention Of Cytomegalovirus Disease In Recipients Of Orthotopic Liver Transplants
收藏DataCite Commons2025-04-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008783/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this research study is to investigate whether or not oral maribavir is safe
and effective compared to oral ganciclovir for preventing CMV disease when administered for
up to 14 weeks in patients who have had a liver transplant.
提供机构：
Vivli
创建时间：
2023-02-10
